Braf V600e Mutation | List of Frontiers open access articles

Clinical Trial

Published on 16 May 2024

Diagnostic value of FNAC combined with BRAFV600E mutation detection in Hashimoto’s thyroiditis complicated with papillary thyroid carcinoma

in Thyroid Endocrinology

Jingyao Fu
Xiangdang Yin
Xiaochun Wang
Siqi Xiao
Xianji Wu
Chengcheng Duan
Wenxi Yu
Guang Zhang

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1366724

2,584 views
2 citations

Original Research

Published on 08 Aug 2025

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma

in Pediatric Oncology

Soha Karim
Amal Mosaab
Hala Taha
Iman Naguib
Amal Refaat
Eslam Maher
Mohamed Saad Zaghloul
Mohamed El-Beltagy
Hanafy Hafez
Mohamed Kamal

Frontiers in Oncology

doi 10.3389/fonc.2025.1537268

2,607 views

Original Research

Published on 12 Apr 2021

Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma

in Thyroid Endocrinology

Xiaojun Zhang
Xu Zhang
Wei Du
Liyuan Dai
Ruihua Luo
Qigen Fang
Hong Ge

Frontiers in Endocrinology

doi 10.3389/fendo.2021.663720

4,019 views
7 citations

Case Report

Published on 25 Jan 2022

Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report

in Pharmacology of Anti-Cancer Drugs

Ziyao Wang
Du He
Chen Chen
Xubao Liu
Nengwen Ke

Frontiers in Oncology

doi 10.3389/fonc.2021.801320

4,296 views
14 citations

Case Report

Published on 17 Nov 2025

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report

in Cancer Immunity and Immunotherapy

Nan Li
Jing Hu
Guangjin Bao
Zhigang Cai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1666461

1,722 views

Original Research

Published on 16 Jun 2022

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation

in Thyroid Endocrinology

Ying Han
Ling Hou
Bowen Zhao
Li Gao
Shiyan Li

Frontiers in Endocrinology

doi 10.3389/fendo.2022.884428

4,135 views
3 citations

Case Report

Published on 29 Sep 2020

Multidisciplinary Therapy Managed Recurrent Glioblastoma in a BRAF-V600E Mutant Pregnant Female: A Case Report and Review of the Literature

in Neuro-Oncology and Neurosurgical Oncology

Chaoying Qin
Wenyong Long
Chi Zhang
Yuanyang Xie
Changwu Wu
Yang Li
Qun Xiao
Nan Ji
Qing Liu

Frontiers in Oncology

doi 10.3389/fonc.2020.522816

4,245 views
7 citations

Case Report

Published on 16 Feb 2026

Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1 expression intolerant to BRAF/MEK inhibition

in Thoracic Oncology

Wei Zhao
Rong Zhou
Chunlai Feng

Frontiers in Oncology

doi 10.3389/fonc.2026.1720971

298 views

Case Report

Published on 08 Aug 2022

Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report

in Cancer Immunity and Immunotherapy

Yuhao Luo
Kelin Mou
Jianmei Wang
Jing Luo
Lin Peng
Hua Ye
Sheng Lin

Frontiers in Immunology

doi 10.3389/fimmu.2022.970879

6,189 views
3 citations

Case Report

Published on 04 Jun 2025

Pleomorphic xanthoastrocytoma with multiple recurrences and continuous malignant progression to bone metastasis: a case report

in Neurosurgery

Lei Tian
Wei Sun
Lei Lou
Wenyan Wang
Yanan Li
Huandi Zhou
Zhiqing Xiao
Xiaoying Xue

Frontiers in Surgery

doi 10.3389/fsurg.2025.1595199

3,124 views

Original Research

Published on 07 Feb 2022

The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine‐Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment

in Thyroid Endocrinology

Xiaojuan Zha
Zhenchun Miao
Xiu Huang
Xingchun Wang
Ruting Xie
Jiaoying Jin
Dajin Zou
Peng Yang
Yueye Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2022.822423

16,895 views
3 citations

Case Report

Published on 05 Oct 2022

Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

in Surgical Oncology

Yuqian Fan
Jingjing Yu
Ming Zhao

Frontiers in Oncology

doi 10.3389/fonc.2022.993414

2,830 views
5 citations

Original Research

Published on 20 May 2021

Melanotic Neuroectodermal Tumor of Infancy: A Clinicopathological and BRAF V600E Mutation Study of 11 Cases

in Pediatric Oncology

Rong-Hui Xia
Chun-Ye Zhang
Li-Zhen Wang
Yu-Hua Hu
Jing-Jing Sun
Zhen Tian
Jiang Li

Frontiers in Oncology

doi 10.3389/fonc.2021.668505

4,470 views
9 citations

Original Research

Published on 16 Apr 2018

Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma

in Experimental Endocrinology

Azliana Mohamad Yusof
Rahman Jamal
Rohaizak Muhammad
Shahrun Niza Abdullah Suhaimi
Isa Mohamed Rose
Sazuita Saidin
Nurul-Syakima Ab Mutalib

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00158

6,940 views
15 citations

Case Report

Published on 08 Aug 2022

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

in Thoracic Oncology

Chaoyuan Liu
Min Lu
Yang Yang
Xiang Wang
Fang Ma
Xianling Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.961539

2,832 views
7 citations

Case Report

Published on 05 Dec 2022

Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association

in Hematologic Malignancies

Luciana Valvano
Fiorella D’Auria
Vitina Grieco
Teodora Statuto
Filomena Nozza
Giuseppe Pietrantuono
Oreste Villani
Giovanni D’Arena
Daniela Lamorte

Frontiers in Oncology

doi 10.3389/fonc.2022.1069977

2,500 views

Articles

Diagnostic value of FNAC combined with BRAFV600E mutation detection in Hashimoto’s thyroiditis complicated with papillary thyroid carcinoma

Prevalence and prognostic impact of BRAF V600E mutation and CDKN2A deletion in pediatric high-grade glioma

Fine Needle Biopsy Versus Core Needle Biopsy Combined With/Without Thyroglobulin or BRAF 600E Mutation Assessment for Detecting Cervical Nodal Metastasis of Papillary Thyroid Carcinoma

Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report

Response to dabrafenib and trametinib combined with pembrolizumab in an elderly patient with lung adenocarcinoma of unknown primary harboring BRAF V600E mutation and high PD-L1 expression: a case report

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation

Multidisciplinary Therapy Managed Recurrent Glioblastoma in a BRAF-V600E Mutant Pregnant Female: A Case Report and Review of the Literature

Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1 expression intolerant to BRAF/MEK inhibition

Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report

Pleomorphic xanthoastrocytoma with multiple recurrences and continuous malignant progression to bone metastasis: a case report

The Risk Stratification of Papillary Thyroid Cancer With Bethesda Category III (Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance) by Thyroid Fine‐Needle Aspiration Could Be Assisted by Tumor Size for Precision Treatment

Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review

Melanotic Neuroectodermal Tumor of Infancy: A Clinicopathological and BRAF V600E Mutation Study of 11 Cases

Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma

Case report: Major pathologic response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with stage IIIA lung adenocarcinoma harboring BRAF V600E-mutation

Case report: Hematologic malignancies concomitant diagnosis of hairy cell leukemia and chronic lymphocytic leukemia: A rare association